A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
M.D. Anderson Cancer Center
Filamon LTD
University of Florida
Jonsson Comprehensive Cancer Center
Novartis
OncoNano Medicine, Inc.
Cancer Research UK
Washington University School of Medicine
Medicenna Therapeutics, Inc.
DEKA Biosciences
Columbia University
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Stanford University
Cedars-Sinai Medical Center
Algemeen Ziekenhuis Maria Middelares
Checkpoint Therapeutics, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
UNICANCER
Klus Pharma Inc.
Revolution Medicines, Inc.
Bristol-Myers Squibb
Rush University Medical Center
Revolution Medicines, Inc.
Allarity Therapeutics
BioNTech SE
Lumos Pharma
Celgene
Stanford University
Santa Maria Biotherapeutics
BIND Therapeutics
Emory University
Calando Pharmaceuticals
New Mexico Cancer Research Alliance
Hoag Memorial Hospital Presbyterian
Netherlands Open University
NS Pharma, Inc.